Correlation Between DexCom and Bio Rad

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both DexCom and Bio Rad at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DexCom and Bio Rad into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DexCom Inc and Bio Rad Laboratories, you can compare the effects of market volatilities on DexCom and Bio Rad and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DexCom with a short position of Bio Rad. Check out your portfolio center. Please also check ongoing floating volatility patterns of DexCom and Bio Rad.

Diversification Opportunities for DexCom and Bio Rad

-0.12
  Correlation Coefficient

Good diversification

The 3 months correlation between DexCom and Bio is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding DexCom Inc and Bio Rad Laboratories in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bio Rad Laboratories and DexCom is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DexCom Inc are associated (or correlated) with Bio Rad. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bio Rad Laboratories has no effect on the direction of DexCom i.e., DexCom and Bio Rad go up and down completely randomly.

Pair Corralation between DexCom and Bio Rad

Given the investment horizon of 90 days DexCom Inc is expected to generate 0.87 times more return on investment than Bio Rad. However, DexCom Inc is 1.15 times less risky than Bio Rad. It trades about 0.07 of its potential returns per unit of risk. Bio Rad Laboratories is currently generating about 0.02 per unit of risk. If you would invest  7,236  in DexCom Inc on August 31, 2024 and sell it today you would earn a total of  574.00  from holding DexCom Inc or generate 7.93% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

DexCom Inc  vs.  Bio Rad Laboratories

 Performance 
       Timeline  
DexCom Inc 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in DexCom Inc are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain fundamental indicators, DexCom may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Bio Rad Laboratories 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Bio Rad Laboratories are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy forward indicators, Bio Rad is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

DexCom and Bio Rad Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with DexCom and Bio Rad

The main advantage of trading using opposite DexCom and Bio Rad positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DexCom position performs unexpectedly, Bio Rad can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Rad will offset losses from the drop in Bio Rad's long position.
The idea behind DexCom Inc and Bio Rad Laboratories pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas